{
  "pmcid": "12369437",
  "sha256": "c53da230aa743f78c15a802fccd4cb89d25e519bdb7ea30a5a684fe8a6528a0a",
  "timestamp_utc": "2025-11-09T23:34:57.480758+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.757878787878791,
    "reading_ease": 18.64431818181822,
    "word_count": 264
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Seroma Management after Groin Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised controlled trial aimed to evaluate the effectiveness of seroma management strategies"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients undergoing groin surgery, with eligibility criteria including age over 18 and no prior groin surgeries. The study was conducted in a tertiary care hospital."
      },
      "Intervention": {
        "score": 2,
        "evidence": "intervention group, receiving the LigaSure electrothermal bipolar sealing device, or the control group, receiving conventional techniques"
      },
      "Objective": {
        "score": 1,
        "evidence": "aimed to evaluate the effectiveness of seroma management strategies"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of seroma formation within 30 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 in each group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on an intention-to-treat basis, with 98 participants in the intervention group and 97 in the control group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "seroma incidence was significantly reduced (mean difference = 12%, 95% CI 5% to 19%; p = 0.002)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were reported in 3% of the intervention group and 1% of the control group, with mild severity."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: None."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}